Filing Details
- Accession Number:
- 0000899243-17-021630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 20:30:48
- Reporting Period:
- 2017-09-06
- Accepted Time:
- 2017-09-07 20:30:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1669477 | W. Raymond Scott | C/O Irhythm Technologies, Inc. 650 Townsend Street, Suite 500 San Francisco CA 94103 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-06 | 4,661 | $8.18 | 4,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-06 | 4,661 | $48.02 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-09-06 | 4,661 | $0.00 | 4,661 | $8.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,088 | 2025-12-15 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $48.00 to $48.15. The price reported above reflects the weighted average sale price. The Reporting Personhereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which thetransaction was effected.
- The option vested and the shares became exercisable according to the following schedule: I/I2 on February 1, 2016 and 1/12 of the shares on each full calendar month thereafter.